Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 10:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2473–2496 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease
Interventions: coenzyme Q10, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 19
States / cities: Little Rock, Arkansas • San Francisco, California • Denver, Colorado + 14 more

Conditions: Stroke, Acute, TIA, Reproducibility of Results, Osteopathic Manipulation, Health-Related Quality-of-Life
Interventions: Not listed
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Obesity, Endothelial Dysfunction, Decreased Vascular Flow
Interventions: Adenosine, Regadenoson; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 88 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Mild Cognitive Impairment, Dementia, Alzheimer's Disease
Interventions: [18F]Flutemetamol; Drug
Lead sponsor: University of Utah; Other
Eligibility: 45 Years to 90 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cognitive Impairment, Mild, Executive Dysfunction
Interventions: RehaCom Computerized Cognitive Training for 480 minutes, Pencil-and-Paper Cognitive Training for 480 minutes; Other
Lead sponsor: University of the Sciences in Philadelphia; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sepsis
Interventions: Conservative Fluid Management Strategy; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Schizophrenia, Negative Symptoms, Cognitive Dysfunction
Interventions: TC-5619, Placebo; Drug
Lead sponsor: Targacept Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 603 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 22
States / cities: Garden Grove, California • Glendale, California • Long Beach, California + 19 more

Conditions: Cerebrovascular Disease, Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 21 Years and older
Enrollment: 840 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2008
U.S. locations: 3
States / cities: Bethesda, Maryland • Silver Spring, Maryland

Conditions: Melanoma
Interventions: Pimonidazole; Drug
Lead sponsor: Yana Najjar; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Mild Cognitive Impairment
Interventions: The Go for Exercise & Healthy Aging Project; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 65 Years to 95 Years
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Mild Cognitive Impairment, Insomnia
Interventions: Multicomponent Behavioral Sleep Intervention for Insomnia, Active Control; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 55 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alzheimer Disease, Progressive Posterior Cortical Dysfunction (PPCD)
Interventions: F 18 T807; Drug
Lead sponsor: Tammie L. S. Benzinger, MD, PhD; Other
Eligibility: 45 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mild Cognitive Impairment
Interventions: computerized cognitive exercises; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 65 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Erectile Dysfunction
Interventions: LY2452473, tadalafil, placebo (tadalafil), placebo (LY2452473); Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years to 70 Years · Male only
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 36
States / cities: Birmingham, Alabama • Phoenix, Arizona • Glendora, California + 33 more

Conditions: Survivorship, Cognitive Dysfunction, Pain, Depression, Anxiety, Fatigue, Sleep Disturbance
Interventions: Cognitive Dysfunction; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 21 Years and older
Enrollment: 682 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Coronary Artery Disease, Mild Cognitive Impairment, Obesity, Abdominal, Hypertension
Interventions: Metformin, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 79 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Mild Cognitive Impairment
Interventions: Dual-Task Exercise Training; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 65 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Cognitive Disorders, HIV Infections
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 25
States / cities: Menlo Park, California • San Diego, California • San Francisco, California + 17 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Aging
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Cardiac Dysfunction
Interventions: Echocardiogram; Diagnostic Test
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: Up to 18 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Immune Thrombotic Thrombocytopenia
Interventions: Caplacizumab; Drug
Lead sponsor: US Thrombotic Microangiopathy Alliance; Other
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Groveport, Ohio

Conditions: Care Giving Burden, Dementia, Chronic Pain, Pain Management, Palliative Care
Interventions: Web-based pain management support tool, Usual Pain Management Care; Other · Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 100 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Erectile Dysfunction, Impotence
Interventions: AMS Penile Prosthesis Devices; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 1,457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 10
States / cities: Homewood, Alabama • Mountain View, California • San Diego, California + 7 more

Conditions: Diabetes Complications
Interventions: Epinephrine, Saline infusion; Drug · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 55 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Clinical Trial of High Dose CoQ10 in ALS

Somatic Dysfunction in Patients With Acute Cerebrovascular Disease

Effects of Body Mass Index on the Hyperemic Response to Regadenoson

Implications for Management of PET Amyloid Classification Technology

Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult?

A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Genetic Studies to Identify Stroke Subtypes and Outcome

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Tai Ji Quan and Cognitive Function in Older Adults With Mild Cognitive Impairment

Multicomponent Behavioral Sleep Intervention for Insomnia in Older Adults With Mild Cognitive Impairment

F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)

Cognitive Training and Practice Effects in Mild Cognitive Impairment

A Study of LY900010 in Erectile Dysfunction

Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms

Genomic Outcomes of Metformin

Home-Based Dual-Task Training for Older Adults

HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient

Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors

E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app

PROPPER Prospective Registry of Outcomes With Penile Prosthesis

Dose Response of Epinephrine